36. Epidermolysis bullosa Clinical trials / Disease details

Clinical trials : 160 / Drugs : 195 - (DrugBank : 47) / Drug target genes : 50 - Drug target pathways : 124

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02582775 (ClinicalTrials.gov)	March 2016	16/10/2015	MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs	MT2015-20: Biochemical Correction of Severe Epidermolysis Bullosa by Allogeneic Cell Transplantation ...	Epidermolysis Bullosa	Drug: Thymoglobulin;Drug: Cyclophosphamide;Drug: Fludarabine;Radiation: Total Body Irradiation;Proce ...	Masonic Cancer Center, University of Minnesota	NULL	Recruiting	N/A	25 Years	All	84	Phase 2	United States
2	NCT01033552 (ClinicalTrials.gov)	January 2010	14/12/2009	Biochemical Correction of Severe EB by Allo HSCT and Off-the-shelf MSCs	MT2009-09: Biochemical Correction of Severe Epidermolysis Bullosa by Allogeneic Stem Cell Transplant ...	Epidermolysis Bullosa	Drug: Cyclophosphamide;Drug: Fludarabine;Drug: Anti-thymocyte globulin;Drug: Cyclosporine A;Drug: Myc ...	Masonic Cancer Center, University of Minnesota	NULL	Recruiting	N/A	25 Years	All	75	Phase 2	United States

First Previous1Next Last